<SEC-DOCUMENT>0000950103-24-005844.txt : 20240426
<SEC-HEADER>0000950103-24-005844.hdr.sgml : 20240426
<ACCEPTANCE-DATETIME>20240426162149
ACCESSION NUMBER:		0000950103-24-005844
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20240426
DATE AS OF CHANGE:		20240426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADC Therapeutics SA
		CENTRAL INDEX KEY:			0001771910
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39071
		FILM NUMBER:		24884144

	BUSINESS ADDRESS:	
		STREET 1:		BIOPOLE
		STREET 2:		ROUTE DE LA CORNICHE 3B
		CITY:			EPALINGES
		STATE:			V8
		ZIP:			1066
		BUSINESS PHONE:		41 21 653 02 00

	MAIL ADDRESS:	
		STREET 1:		BIOPOLE
		STREET 2:		ROUTE DE LA CORNICHE 3B
		CITY:			EPALINGES
		STATE:			V8
		ZIP:			1066
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>dp209891_defa14a.htm
<DESCRIPTION>FORM DEFA 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNITED STATES
</B></FONT><B><BR>
<FONT STYLE="font-size: 12pt">SECURITIES AND EXCHANGE COMMISSION </FONT><BR>
Washington, D.C. 20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A<BR>
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the registrant <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT><BR>
Filed by a party other than the Registrant <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Preliminary Proxy Statement</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Definitive Proxy Statement</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD><TD>Definitive Additional Materials</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Soliciting Material under &sect; 240.14a-12</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>ADC Therapeutics
SA</B></FONT><B><BR>
</B>(Name of registrant as specified in its charter)<BR>
(Name of person(s) filing proxy statement, if other than the registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check all boxes that apply):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD><TD>No fee required</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Fee paid previously with preliminary materials</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Fee computed on table in exhibit required by Item 25(b) per
Exchange Act Rules 14a-6(i)(1) and 0-11</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 30pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.5pt 0pt 0; text-align: right"><FONT STYLE="color: #231F20"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 30pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-left: 0.375in; width: 75%">&nbsp;<IMG SRC="image_001.jpg" ALT=""></TD>
  <TD STYLE="text-align: right; width: 25%">+</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 10pt 0pt 0pt; text-align: left"><FONT STYLE="color: #231F20">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: left"><FONT STYLE="color: #231F20">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.5pt 0pt 0; text-align: right"><FONT STYLE="color: #231F20"></FONT></P>

<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: right; width: 68%; vertical-align: middle"><IMG SRC="image_003.jpg" ALT=""></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 31%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><B>Online</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.25in 0pt 0; text-align: right; color: #231F20">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20">Go to <B>www.envisionreports.com/ADCT
</B>or scan the QR code &mdash; login details are located in the shaded bar below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt; color: #231F20"><B>Electronic
voting instructions must be received by Computershare no later than June 10, at 11:59 p.m. EDT / June 11 at 5:59 a.m.
CEST</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><B>Proxy
cards by mail must be received by Computershare no later than June 6, at 11:59 p.m. EDT / June 7 at 5:59 a.m. CEST</B></P>

</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.5pt 0pt 0; text-align: right"><FONT STYLE="color: #231F20">&nbsp;</FONT>&nbsp;&nbsp;</P>

<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<TR STYLE="background-color: rgb(220,221,222); vertical-align: top; text-align: left">
  <TD STYLE="border-top: Black 2pt solid; border-bottom: Black 2pt solid; width: 68%"><P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.4pt; color: #231F20"><B>ADC
                                            Therapeutics SA Shareholder Meeting Notice</B></P>
</TD>
    <TD STYLE="border-top: Black 2pt solid; border-bottom: Black 2pt solid; width: 32%">&nbsp;<IMG SRC="image_002.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.25in 0pt 0; text-align: right; color: #231F20"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: right; color: #231F20"></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 3pt 2.25in 0pt; text-align: center; color: #231F20"><B>Important
Notice Regarding the Availability of Proxy Materials for the ADC Therapeutics SA Shareholder Meeting to be Held on</B></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.5in; text-align: center; color: #231F20"><B>Thursday,
June 13, 2024 at 4:00 a.m. EDT / 10:00 a.m. CEST</B></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.5in 3pt; text-align: center; color: #231F20"><B>at Biop&ocirc;le, Route
de la Corniche 3B, 1066 Epalinges, Switzerland</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt; text-align: justify; color: #231F20">You are
receiving this notice that the proxy materials for the annual shareholders&rsquo; meeting are available on the Internet. Follow the instructions
below to view the materials and vote online or request a copy. The items to be voted on and location of the annual meeting are on the
reverse side. Your vote is important!</P>

<P STYLE="margin: 0pt 0 3pt; font-size: 10pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>This communication
presents only an overview of the more complete proxy materials that are available to you on the internet. You are encouraged to access
and view the complete proxy materials before voting. This proxy materials, including our Annual Report on Form 10-K, management report,
annual financial statements, consolidated financial statements, auditors&rsquo; reports and compensation report for the year ended December
31, 2023, are available for viewing, printing and downloading at:</B></FONT></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; color: #231F20"><IMG SRC="image_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 3pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"><B>Additionally,
you can find a copy of the Proxy Statement and our Annual Report on Form 10-K on the website of the U.S. Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) at sec.gov. You may also obtain a printed copy of the proxy materials at no cost, upon written or oral request
to us at the following address: Investor Relations, ADC Therapeutics SA, c/o ADC Therapeutics America, Inc., 430 Mountain Avenue, 4th
Floor, Murray Hill, NJ 07974, (908) 731-5556.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>


<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 7pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 10%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt"></FONT></P>
                         <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;<IMG SRC="image_005.jpg" ALT="">&nbsp;&nbsp;</FONT></P></TD>
    <TD STYLE="width: 80%"><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 14pt"><B>Easy
                           Online Access &mdash; View your proxy materials and vote.</B></FONT></P>
                           <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>
                           <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Step
                           1:</B>&#9;&nbsp;&nbsp;&nbsp;Go to <B>www.envisionreports.com/ADCT</B>.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Step
2:</B>&#9;&nbsp;&nbsp;&nbsp;Click on <B>Cast Your Vote or Request Materials.</B></FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Step
3:</B>&#9;&nbsp;&nbsp;&nbsp;Follow the instructions on the screen to log in.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Step
4:</B>&nbsp;&nbsp;&nbsp;&#9;Make your selections as instructed on each screen for your delivery preferences.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Step
5</B>:&#9;&nbsp;&nbsp;&nbsp;Vote your shares.</FONT></P>

</TD>
  <TD STYLE="width: 10%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"></P> <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 105.8pt 0pt 78pt; color: #231F20">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>When
you go online, you can also help the environment by consenting to receive electronic delivery of future materials.</B></FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; color: #231F20">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; color: #231F20"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red"><B></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red"></P>

<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 10%">&nbsp;&nbsp;&nbsp;<IMG SRC="image_006.jpg" ALT=""></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-size: 10pt"><B>Obtaining a Copy of the Proxy Materials &ndash; If you want to receive a copy of the proxy materials,
    you must request one. There is no charge to you for requesting a copy. Please make your request as instructed on the reverse side
    on or before May 31, 2024 to facilitate timely delivery.</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: left; width: 50%; vertical-align: bottom"><FONT STYLE="font-size: 30pt">&nbsp;<IMG SRC="image_008.jpg" ALT=""></FONT></TD>
    <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-size: 30pt">+</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 9.45pt 0pt 78pt; text-align: justify; color: #231F20"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.45pt 0pt 0; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT><FONT STYLE="font-size: 30pt; color: #231F20"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 14.45pt 0pt 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"></P>

<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<TR STYLE="background-color: rgb(220,221,222); vertical-align: top; text-align: left">
  <TD STYLE="border-top: Black 2pt solid; border-bottom: Black 2pt solid; width: 68%"><P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.4pt; color: #231F20"><B>ADC
                                            Therapeutics SA Shareholder Meeting Notice</B></P>
</TD>
    <TD STYLE="border-top: Black 2pt solid; border-bottom: Black 2pt solid; width: 32%">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 9pt"><B>ADC
Therapeutics SA&rsquo;s Annual General Meeting of Shareholders will be held on Thursday, June 13, 2024, at the headquarter of ADC Therapeutics
SA, Biop&ocirc;le, Route de la Corniche 3B, 1066 Epalinges, Switzerland, at 4:00 a.m. EDT / 10:00 a.m. CEST</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 9pt"><B>Proposals
to be voted on at the meeting are listed below along with the Board of Directors&rsquo; recommendations.</B></FONT></P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 9pt"></FONT></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 3pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 9pt"><B></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 3pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 9pt"><B>The
Board of Directors recommends a vote FOR Proposals 1-10 and 12 and 1 YEAR on Proposal 11: Agenda and Proposals of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposals
to be voted on at the meeting are listed below along with the Board of Directors&rsquo; recommendations.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">1.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Approving
                                            the Management Report, Annual Financial Statements and Consolidated Financial Statements</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors proposes that the Management Report, the Annual Financial Statements and the Consolidated Financial Statements for
the year ended December 31, 2023, be approved, and the Auditors&rsquo; Reports for the year ended December 31, 2023, be acknowledged.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">2.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Approving,
                                            on an advisory basis under Swiss law, the Compensation Report</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors proposes that the Company&rsquo;s Compensation report for the year ended December 31, 2023, be approved in a non-binding
advisory vote.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">3.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Discharging
                                            the members of the Board of Directors and the Executive Committee from liability</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors proposes that the members of the Board of Directors and the Executive Committee be discharged from liability for the
year ended December 31, 2023.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">4.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Approving
                                            the appropriation of the financial results</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
board of directors proposes that the net loss for the year ended December 31, 2023, be carried forward as follows:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-size: 9pt">Loss carried forward from the year ended December 31, 2022</FONT></TD>
  <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 9pt">CHF</FONT></TD>
  <TD><FONT STYLE="font-size: 9pt">968,963,858</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">Loss for the year ended December 31, 2023</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">CHF</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">144,426,257</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-size: 9pt">Loss to be carried forward&#9;</FONT></TD>
  <TD><FONT STYLE="font-size: 9pt">CHF</FONT></TD>
  <TD><FONT STYLE="font-size: 9pt">1,113,390,115</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt; margin-left: 23.85pt; text-indent: 0.1pt; color: #231F20"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt; margin-left: 24pt; color: #231F20"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">5.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Reelecting
                                            nominees to the Board of Directors</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5a: The Board of Directors proposes that Ron Squarer be reelected as the Chair of the Board of Directors and a director for a one-year
term, beginning as of the Annual Meeting and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5b: The Board of Directors proposes that Robert Azelby be reelected as a director for a one-year term, beginning as of the Annual Meeting
and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5c: The Board of Directors proposes that Jean-Pierre Bizzari be reelected as a director for a one-year term, beginning as of the Annual
Meeting and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5d: The Board of Directors proposes that Peter Hug be reelected as a director for a one-year term, beginning as of the Annual Meeting
and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5e: The Board of Directors proposes that Ameet Mallik be reelected as a director for a one-year term, beginning as of the Annual Meeting
and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5f: The Board of Directors proposes that Viviane Monges be reelected as a director for a one-year term, beginning as of the Annual Meeting
and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5g: The Board of Directors proposes that Thomas Pfisterer be reelected as a director for a one-year term, beginning as of the Annual
Meeting and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5h: The Board of Directors proposes that Tyrell Rivers be reelected as a director for a one-year term, beginning as of the Annual Meeting
and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#5i: The Board of Directors proposes that Victor Sandor be reelected as a director for a one-year term, beginning as of the Annual Meeting
and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 23.95pt; color: #231F20"><FONT STYLE="font-size: 9pt"></FONT></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 23.95pt; color: #231F20"><FONT STYLE="font-size: 9pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">6.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Reelecting
                                            nominees to the Compensation Committee of the Board of Directors</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#6a: The Board of Directors proposes that Robert Azelby be reelected as a member of the Compensation Committee for a one-year term, beginning
as of the Annual Meeting and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#6b: The Board of Directors proposes that Peter Hug be reelected as a member of the Compensation Committee for a one-year term, beginning
as of the Annual Meeting and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#6c: The Board of Directors proposes that Victor Sandor be reelected as a member of the Compensation Committee for a one-year term, beginning
as of the Annual Meeting and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">7.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Reelecting
                                            the Independent Proxy</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors proposes that PHC Notaires, in Lausanne, Switzerland, be reelected as the Independent Proxy for a one-year term, beginning
as of the Annual Meeting and ending at the closing of the 2025 annual general meeting of shareholders.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">8.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Reelecting
                                            the Auditors</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors proposes that PricewaterhouseCoopers SA be reelected as the statutory auditor and independent registered public accounting
firm for the year ending December 31, 2024.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">9.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Approving,
                                            on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive
                                            Committee</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#9a: The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for
the period between the Annual Meeting and the 2025 annual general meeting of shareholders be set at $2,000,000.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#9b: The Board of Directors proposes that the maximum aggregate amount of fixed compensation for the members of the Executive Committee
for the year ending December 31, 2025, be set at $3,000,000.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#9c: The Board of Directors proposes that the maximum aggregate amount of variable compensation for the members of the Executive Committee
for the year ending December 31, 2024, be set at $10,000,000.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">10.</TD><TD><FONT STYLE="font-size: 9pt">Approving, on an advisory basis
under U.S. law, the compensation paid to the Named Executive Officers</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors is proposing that the following proposal: &ldquo;RESOLVED, that the Company&rsquo;s shareholders approve, on an advisory
basis under U.S. law, the compensation of the Company&rsquo;s Named Executive Officers, as disclosed in &ldquo;Executive Compensation&rdquo;
and the related compensation tables and narrative disclosure in this proxy statement&rdquo;, be approved.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">11.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Approving, on an advisory basis
under U.S. law, the frequency of future votes on the compensation paid to the Named Executive Officers</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors is proposing that the shareholders advise on the frequency of future advisory votes on Named Executive Compensation
by voting for either &ldquo;ONE YEAR&rdquo;, &ldquo;TWO YEARS&rdquo; OR &ldquo;THREE YEARS&rdquo;.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">The
Board of Directors recommends shareholders vote ONE YEAR on this proposal.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 9pt">12.</FONT></TD><TD><FONT STYLE="font-size: 9pt">Approving amendments to the Articles
of Association</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#12a: The Board of Directors proposes that the amendments to the Articles of Association relating to shares, shareholder rights and general
meetings be approved. Proposal #12b: The Board of Directors proposes that the amendments to the Articles of Association regarding the
deadline for submitting agenda items be approved.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#12c: The Board of Directors proposes that the amendments to the Articles of Association relating to board of directors, compensation
and related matters be approved. Proposal #12d: The Board of Directors proposes that the amendments to the Articles of Association for
conditional share capital flexibility be approved.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#12e: The Board of Directors proposes that the amendments to the Articles of Association to permit shareholder meetings outside Switzerland
and hybrid and virtual shareholder meetings be approved.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0in"><FONT STYLE="font-size: 9pt">Proposal
#12f: The Board of Directors proposes that the amendments to the Articles of Association relating to the jurisdiction of Swiss courts
be approved.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-indent: 0.1pt; color: #231F20"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-indent: 0.1pt; color: #231F20"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 3pt 69pt"></P>



<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 3pt 0pt 3pt 69pt"><FONT STYLE="color: #231F20"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 4pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-top: Black 1pt solid; width: 69pt"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>
                                                       <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<IMG SRC="image_007.jpg" ALT="">&nbsp;</P></TD>
  <TD STYLE="border-top: Black 1pt solid"><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 3pt; margin-right: 0pt; margin-bottom: 3pt"><FONT STYLE="color: #231F20"><B>Here&rsquo;s
                                          how to order a copy of the proxy materials and select delivery preferences:</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in">Current
and future delivery requests can be submitted using the options below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in">If
you request an email copy, you will receive an email with a link to the current meeting materials.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"><B>PLEASE
NOTE:</B> You must use the number in the shaded bar on the reverse side when requesting a copy of the proxy materials.</P>

</TD></TR>
</TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt; margin-left: 0in; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 69pt"></TD><TD STYLE="width: 18pt">&mdash;</TD><TD><B>Internet</B> &ndash; Go to <B>www.envisionreports.com/ADCT</B>.
                                            Click Cast Your Vote or Request Materials.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 69.05pt"></TD><TD STYLE="width: 18pt">&mdash;</TD><TD><B>Phone</B> &ndash; Call us free of charge at 1-866-641-4276.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 69.35pt"></TD><TD STYLE="width: 17.7pt">&mdash;</TD><TD STYLE="padding-right: 0.2in"><B>Email</B> &ndash; Send an email
                                            to investorvote@computershare.com with &ldquo;Proxy Materials ADC Therapeutics SA&rdquo;
                                            in the subject line. Include your full name and address, plus the number located in the shaded
                                            bar on the reverse side, and state that you want a paper copy of the meeting materials.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 3pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 87pt; color: #231F20">To facilitate timely delivery, all requests
for a paper copy of proxy materials must be received by May 31, 2024.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 87pt; color: #231F20">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !4 8L# 2(  A$! Q$!_\0
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MP\LTKF2T689+L3S,<_\ COY^E>V5FVFLZ++(EG9ZG8.ZC:L,4Z$@#L%!K2H
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M[&UWJ9;>!8Y%!Z$#'Y4 :]%%%(851UB,2Z5./1=P_ YJ]535"%TNY)_YYD4
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MK*B//DW0',3'K[J>_P#.@#;HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*P_&G_(B^(?^P9<_^BFK<J"]LX-1L+BRNH_,M[B)H94R1N1A@C(Y'!/2@#RO
MP)J'A.]^$-CH6NZMI<8D6998)[N-'3,SD'!.0>A!^AJ'X>:%X/\ !M_>:A=>
M+-#N[MG:.V<7L7[N+UZ\,>_IT'>NI_X5!X$_Z 7_ )-S_P#Q='_"H/ G_0"_
M\FY__BZ!FY_PFGA7_H9=&_\  ^+_ .*KRWXFQ^&CO\7^&_$]E!KUN4)CLKN-
MFGRP7("MG(!R>N0#D=Z[;_A4'@3_ * 7_DW/_P#%T?\ "H/ G_0"_P#)N?\
M^+H Y*QLOBWXET:U<Z[96UE>0)*)@%20HX!'W$R#@]L?6NZ\#^!+#P382)#(
MUS>W&#<74@P7([ =AU_K[=)96<&G6%O96L?EV]O$L,29)VHHP!D\G@#K4] C
MB_B=X0U#QIX;M].TZ:VBFBO%G+7#,J[0CKCY5)SEAVKM*** /(1X"^(6D^)-
M=U'P[KFDV<.J7CSLLF78KO=D!W1, 0'/0_G5K^POC)_T-FC?]^E_^,5ZI10
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M%U*#3+6*2SD5TB56'H<4Q&D?$%__ 'T_[XJO-JU]."'N' (QA?E_E1_9-_\
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C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O #T# 2(  A$! Q$!_\0
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M45Q_Q* _X1:"3 WQZI8NC=U/VF,9'X$UV% '-?$+_DG'B3_L&S_^@&MO3/\
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EVGZ+JUO;"\@N;R\O[-[9(XXY!)M4/@NQ* <# SDUW]%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  = -0# 2(  A$! Q$!_\0
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M) _] I?^$7O_ /H;-9_\@_\ Q%=)10!S?_"+W_\ T-FL_P#D'_XBC_A%[_\
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M9/GGC5!)#.?5HR1\WN"* .GHKS!_'/B2)VC+:6VTD9-I)S_Y%IO_  GGB/\
MZA7_ ("R?_': /4:*\N_X3SQ'_U"O_ 63_X[1_PGGB/_ *A7_@+)_P#': /4
M:*\N_P"$\\1_]0K_ ,!9/_CM'_">>(_^H5_X"R?_ !V@#U&BO+O^$\\1_P#4
M*_\  63_ ..T?\)YXC_ZA7_@+)_\=H ]1HKR[_A//$?_ %"O_ 63_P".T?\
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..4'\:*[0  8' HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ^ F,# 2(  A$! Q$!_\0
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M (]_]:LZB@#1_M7_ *8_^/?_ %J/[5_Z8_\ CW_UJSJ* -'^U?\ IC_X]_\
M6H_M7_IC_P"/?_6K.HH T?[5_P"F/_CW_P!:C^U?^F/_ (]_]:LZB@#1_M7_
M *8_^/?_ %J/[5_Z8_\ CW_UJSJ* -'^U?\ IC_X]_\ 6H_M7_IC_P"/?_6K
M.HH T?[5_P"F/_CW_P!:C^U?^F/_ (]_]:LZB@#1_M7_ *8_^/?_ %J/[5_Z
M8_\ CW_UJSJ* -'^U?\ IC_X]_\ 6H_M7_IC_P"/?_6K.HH T?[5_P"F/_CW
M_P!:C^U?^F/_ (]_]:LZB@#1_M7_ *8_^/?_ %J/[5_Z8_\ CW_UJSJ* -'^
MU?\ IC_X]_\ 6H_M7_IC_P"/?_6K.HH T?[5_P"F/_CW_P!:C^U?^F/_ (]_
M]:LZB@#1_M7_ *8_^/?_ %J/[5_Z8_\ CW_UJSJ* -'^U?\ IC_X]_\ 6H_M
M7_IC_P"/?_6K.HH T?[5_P"F/_CW_P!:C^U?^F/_ (]_]:LZB@#1_M7_ *8_
M^/?_ %J/[5_Z8_\ CW_UJSJ* -'^U?\ IC_X]_\ 6H_M7_IC_P"/?_6K.HH
MT?[5_P"F/_CW_P!:C^U?^F/_ (]_]:LZB@#1_M7_ *8_^/?_ %J/[5_Z8_\
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M,\$+U (S]17*>)M7N->^(>DV\$-W-IGV>.>W$$YB\U3EC,,C(QR"",_(>F>
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M!92%\@%8]HP>O''-=[10*YXCX?\ "6KV&KZ7--X?FMC:F;[7=M,&$N5.#C/
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M $H_LR+^^_Z4 9=%:G]F1?WW_2C^S(O[[_I0!ET5J?V9%_??]*/[,B_OO^E
M&716I_9D7]]_TH_LR+^^_P"E &716I_9D7]]_P!*/[,B_OO^E &716I_9D7]
M]_TH_LR+^^_Z4 9=%:G]F1?WW_2C^S(O[[_I0!ET5J?V9%_??]*/[,B_OO\
MI0!ET5J?V9%_??\ 2C^S(O[[_I0!ET5J?V9%_??]*/[,B_OO^E &716I_9D7
L]]_TJ6.Q@CYV[C_M'- &;;VKW#<#"=V-;,<:Q($08 IP&!@44AA1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& $T# 2(  A$! Q$!_\0
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..*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ #(# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  > " # 2(  A$! Q$!_\0
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M3PM>ZW]E^U?9MG[GS-F[<ZI][!Q][/3M7EG_  T/_P!2M_Y4/_M==O\ %_\
MY);K/_;#_P!'QU\L4#1[A_PT/_U*W_E0_P#M==3X!^*G_"<:[/IG]C?8O*MF
MN/,^U>9G#*N,;!_>ZY[5\S5ZI\ _^1ZOO^P9)_Z-BH ]3^+_ /R2W6?^V'_H
M^.OEBOLKQ)H%KXHT"YT:]DFCM[C9O:%@'&U@PP2".JCM7 ?\*#\*_P#00UG_
M +_1?_&Z 1\Z5ZI\ _\ D>K[_L&2?^C8J[?_ (4'X5_Z"&L_]_HO_C==!X0^
@&.B^"]6EU'3KJ_EFE@,!6XD1EVEE;/RH#G*CO0%S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ #(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^N2\;>/;
M'P?!%;K$U_K-U\MGIT!S)*3P"<=%]_RJIXW\:WVEZA;^&_#=@U_XDO(_,C0C
M]W;QYQYLA],@_P"< KX)^'EOX;N)M9U2Y.J^)+L[KF_FY*DCE8_[J]O7'' P
M  <QX6\6?%3Q7#J#VUIX2M'L+Q[*XBNUN RRIC</D9@1SCKVK>_XN_\ ]2-_
MY-U'\*O^/KQS_P!C/>?S6O1* //_ /B[_P#U(W_DW5/4O%/C_P (11:KXJM/
M#<^BB9(KEM,>9980S!0_[S@@$]/Y5Z97G?QR_P"22ZM_OP?^CDH ]$HHHH \
M[B_Y.)G_ .Q8'_I2*ZG7]#O]8: V7B&_TD1!@PM5C/F9QC.]3TQV]:Y:+_DX
MF?\ [%@?^E(KK_$'B"V\.:>MY=6U[.C2",+9VS3-D@G)"]!QU/M0!1\(>$8O
M"-MJ$:7]S?2W]X][/-<!0QD8#=]T =L_C71UPG_"U]'_ .@/XC_\%4E'_"U]
M'_Z _B/_ ,%4E '=UYW\<O\ DDNK?[\'_HY*W_#WC:P\27TEI:V&K6[I'YA:
M[L7B0C(&-Q&,\]*P/CE_R275O]^#_P!')0!Z)1110!YW%_R<3/\ ]BP/_2D5
MUOB377\/:8+U-(U+5"9 GD:=#YL@SGG;D<<?K7)1?\G$S_\ 8L#_ -*176>)
M/$">&],%\^FZEJ ,@C\G3K?SI.<\XR...M ')_\ "U9_^B?>-/\ P5G_ !H_
MX6K/_P!$^\:?^"L_XT?\+<@_Z$GQI_X*A_\ %T?\+<@_Z$GQI_X*A_\ %T ;
M?ACQE+XDO9K=_#&OZ4(X]_FZE:>2C<XP#GDUB?'+_DDNK?[\'_HY*V_#'C>+
MQ/>S6R>']?TTQQ[_ #-2LO)1N<8!W'GVK$^.7_))=6_WX/\ T<E 'HE%%% '
MG49"_M%2@D#=X8P,]_\ 2!_@:]%K \1>#=%\42VT^HV\GVJUSY-S;S-#*@/4
M!E(./:LK_A5^A?\ /[KG_@VG_P#BJ .THKB_^%7Z%_S^ZY_X-I__ (JC_A5^
MA?\ /[KG_@VG_P#BJ .TKSOXX_-\*-3C'+O+ J*.K'S4X'J:T/\ A5^A?\_N
MN?\ @VG_ /BJ?:_#+PW;ZA;7LJ7UY):R>;"M[?2SHCCHVUF(R* .QHHHH __
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
